BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/25/2024 7:15:47 AM | Browse: 445 | Download: 1010
Publication Name World Journal of Stem Cells
Manuscript ID 94408
Country India
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Review
Article Title Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury
Manuscript Source Invited Manuscript
All Author List Prashasti Sharma and Dharmendra Kumar Maurya
ORCID
Author(s) ORCID Number
Prashasti Sharma http://orcid.org/0009-0003-8045-1353
Dharmendra Kumar Maurya http://orcid.org/0000-0003-0909-363X
Funding Agency and Grant Number
Corresponding Author Dharmendra Kumar Maurya, BSc, MSc, PhD, N/A, N/A, Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre, 3-82-S, A-block, Modular Laboratory, Mumbai 400085, Maharashtra, India. dkmaurya@barc.gov.in
Key Words Stem cells; Wharton’s jelly mesenchymal stem cells; Radiotherapy; Xerostomia; Lung fibrosis
Core Tip Stem cells, particularly Wharton’s Jelly mesenchymal stem cells (WJ-MSCs), are pivotal in cell-based therapy due to their robust tissue repair abilities. While radiotherapy is a common cancer treatment, it often causes collateral damage to healthy tissues, reducing its efficacy. WJ-MSCs, resembling embryonic stem cells, exhibit superior differentiation and safety, making them ideal for both autologous and allogeneic transplants. This review emphasizes WJ-MSCs’ regenerative potential and clinical utility in alleviating radiation-induced injuries resulting from radiotherapy across various cancer types.
Publish Date 2024-07-25 07:15
Citation

Sharma P, Maurya DK. Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury. World J Stem Cells 2024; 16(7): 742-759

URL https://www.wjgnet.com/1948-0210/full/v16/i7/742.htm
DOI https://dx.doi.org/10.4252/wjsc.v16.i7.742
Full Article (PDF) WJSC-16-742-with-cover.pdf